Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Jul 31, 2025 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (FY)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 141.92%2.59B | 35.62%1.07B | 78.60%291.62M | 51.86%288.73M | 279.1M | 212.51M | -18.39%790.38M | 163.28M | 190.13M | 130.91%968.52M |
| Cost of revenue | 278.78%1.27B | 21.78%334.59M | 162.08%96.01M | -16.24%70.11M | 93.1M | 75.37M | -22.82%274.74M | 36.63M | 83.71M | 56.14%355.95M |
| Gross profit | 79.82%1.33B | 43.00%737.37M | 54.46%195.61M | 105.42%218.62M | 186M | 137.14M | -15.82%515.65M | 126.64M | 106.43M | 219.91%612.58M |
| Operating expense | 78.37%1.04B | 31.29%584.63M | 11.80%172.65M | 50.04%137.34M | 142.56M | 132.09M | -19.93%445.3M | 154.42M | 91.53M | 59.80%556.17M |
| Operating profit | 85.37%283.14M | 117.12%152.74M | 182.67%22.96M | 445.65%81.29M | 43.44M | 5.05M | 24.72%70.35M | -27.78M | 14.9M | 136.03%56.4M |
| Net non-operating interest income (expenses) | 4,141.18%721K | 30.77%17K | 0.00%1K | 50.00%9K | 0 | 7K | 0.00%13K | 1K | 6K | 85.71%13K |
| Non-operating interest income | 6,811.76%1.18M | 30.77%17K | 0.00%1K | 50.00%9K | --0 | --7K | 0.00%13K | --1K | --6K | 85.71%13K |
| Non-operating interest expense | --454K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -1.51M | 0 | 0 | 0 | 79K | 0 | 0 | 0 | ||
| Less:Other special charges | --1.51M | ---- | ---- | ---- | ---- | ---- | ---79K | --0 | --0 | ---- |
| Other non-operating income (expenses) | 3,181.85%8.5M | 102.71%259K | 116.48%15K | 101.16%111K | -117.98%-9.54M | -91K | -9.56M | 480.09%53.08M | ||
| Income before tax | 90.08%290.85M | 151.27%153.01M | 182.45%22.98M | 1,423.85%81.4M | 43.58M | 5.06M | -44.39%60.9M | -27.87M | 5.34M | 174.29%109.5M |
| Income tax | 228.01%102.72M | 91.75%31.32M | -67.15%-12.96M | 2,041.66%28.52M | 13.75M | 2M | 140.27%16.33M | -7.75M | -1.47M | -3,082.35%-40.56M |
| Net income | 54.58%188.12M | 173.08%121.7M | 278.65%35.94M | 676.31%52.88M | 29.83M | 3.05M | -70.30%44.56M | -20.12M | 6.81M | 200.87%150.06M |
| Net income continuous operations | 54.58%188.12M | 173.08%121.7M | 278.65%35.94M | 676.41%52.88M | --29.83M | --3.05M | -70.30%44.56M | ---20.12M | --6.81M | 200.87%150.06M |
| Noncontrolling interests | 48.5M | |||||||||
| Net income attributable to the company | 14.73%139.63M | 173.08%121.7M | 278.65%35.94M | 676.31%52.88M | 29.83M | 3.05M | -70.30%44.56M | -20.12M | 6.81M | 200.87%150.06M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 14.73%139.63M | 173.08%121.7M | 278.65%35.94M | 676.31%52.88M | 29.83M | 3.05M | -70.30%44.56M | -20.12M | 6.81M | 200.87%150.06M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 12.61%36 | 154.94%31.97 | 253.86%9.37 | 623.50%13.93 | 7.87 | 0.8 | -71.05%12.54 | -6.09 | 1.9254 | 200.87%43.3185 |
| Diluted earnings per share | 14.25%34.87 | 158.64%30.52 | 247.78%9 | 638.00%13.25 | 7.51 | 0.76 | -70.16%11.8 | -6.09 | 1.7954 | 192.10%39.5508 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |